Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234264 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2680343 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2680240 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL17090764 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL476072 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL3971104 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL475859 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL502670 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL17090801 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL17090772 | 1.00 | TSHR (0.53) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2552385-B1 | PREPARATIONS COMPRISING DIHYDROXYACETONE | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | claimed |
| WO-2022264724-A1 | METHOD FOR PRODUCING POLYMER, AND COMPOUND, PALLADIUM COMPLEX, AND COMPOSITION | 住友化学株式会社 | 2022-12-22 | — | — | WO | disclosed |
| CN-110003271-B | Process for producing aromatic compound | 住友化学株式会社 | 2022-05-03 | — | — | CN | disclosed |
| WO-2022059590-A1 | LIGHT- OR HEAT-RESPONSIVE CLEAVAGE MOLECULAR LAYER | 国立研究開発法人産業技術総合研究所 | 2022-03-24 | — | — | WO | disclosed |
| US-11045796-B2 | Process for producing aromatic compound, and palladium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-29 | — | — | US | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-2485289-B1 | LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-03 | — | — | EP | disclosed |
| CN-108368142-B | Method for producing aromatic compound and palladium complex | 住友化学株式会社 | 2021-02-19 | — | — | CN | disclosed |
| US-10854818-B2 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-12-01 | — | — | US | disclosed |
| US-20020027623-A1 | Polymeric fluorescent substance, production method thereof, and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-07 | — | — | US | disclosed |
| EP-1182245-A1 | Polymeric fluorescent substance and polymer light emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1138746-A1 | Polymeric fluorescent substance, production method therof, and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
| EP-1134269-A2 | Polymeric fluorescent substance, polymeric fluorescent substance solution and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-19 | — | — | EP | disclosed |
| US-20010020085-A1 | Polymeric fluorescent substance and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1116768-A2 | Polymeric fluorescent substance and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-18 | — | — | EP | disclosed |
| EP-1074600-A2 | Polymeric fluorescent substance and polymer light emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-02-07 | — | — | EP | disclosed |
| EP-1043382-A2 | Polymeric fluorescent substance and polymer light emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-0964045-A1 | Polymeric fluorescent substance and organic electroluminescence device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| EP-0517262-A1 | Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045796-B2 | Process for producing aromatic compound, and palladium complex | DDT, DRD1, DRD2 | TSHR 1067/4885THRB 2911/4885DNM1 1527/4885 |
| US-10854818-B2 | Dendrimer compound and organic luminescent device employing the same | DCUN1D4, DCUN1D1, FLOT1 | TSHR 3807/4885THRB 3244/4885DNM1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.